JP2011505809A5 - - Google Patents

Download PDF

Info

Publication number
JP2011505809A5
JP2011505809A5 JP2010537144A JP2010537144A JP2011505809A5 JP 2011505809 A5 JP2011505809 A5 JP 2011505809A5 JP 2010537144 A JP2010537144 A JP 2010537144A JP 2010537144 A JP2010537144 A JP 2010537144A JP 2011505809 A5 JP2011505809 A5 JP 2011505809A5
Authority
JP
Japan
Prior art keywords
meganuclease
sequence
eukaryotic cell
chromosome
cleavage site
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010537144A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011505809A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/085878 external-priority patent/WO2009076292A2/en
Publication of JP2011505809A publication Critical patent/JP2011505809A/ja
Publication of JP2011505809A5 publication Critical patent/JP2011505809A5/ja
Pending legal-status Critical Current

Links

JP2010537144A 2007-12-07 2008-12-08 ヒトゲノムのDNase高感受性領域に見出される認識配列を有する合理的に設計されたメガヌクレアーゼ Pending JP2011505809A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US568607P 2007-12-07 2007-12-07
PCT/US2008/085878 WO2009076292A2 (en) 2007-12-07 2008-12-08 Rationally-designed meganucleases with recognition sequences found in dnase hypersensitive regions of the human genome

Publications (2)

Publication Number Publication Date
JP2011505809A JP2011505809A (ja) 2011-03-03
JP2011505809A5 true JP2011505809A5 (enExample) 2012-02-02

Family

ID=40756084

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010537144A Pending JP2011505809A (ja) 2007-12-07 2008-12-08 ヒトゲノムのDNase高感受性領域に見出される認識配列を有する合理的に設計されたメガヌクレアーゼ

Country Status (6)

Country Link
US (2) US20110033935A1 (enExample)
EP (1) EP2215252A4 (enExample)
JP (1) JP2011505809A (enExample)
AU (1) AU2008335324A1 (enExample)
CA (1) CA2703079A1 (enExample)
WO (1) WO2009076292A2 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011036640A2 (en) * 2009-09-24 2011-03-31 Cellectis Meganuclease reagents of uses thereof for treating genetic diseases caused by frame shift/non sense mutations
EP2504429B1 (en) 2009-11-27 2016-04-20 BASF Plant Science Company GmbH Chimeric endonucleases and uses thereof
DE112010004582T5 (de) 2009-11-27 2012-11-29 Basf Plant Science Company Gmbh Optimierte Endonukleasen und Anwendungen davon
JP2013511979A (ja) 2009-11-27 2013-04-11 ビーエーエスエフ プラント サイエンス カンパニー ゲーエムベーハー キメラエンドヌクレアーゼおよびその使用
WO2011095475A1 (en) * 2010-02-02 2011-08-11 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for the diagnosis and therapy of retinitis pigmentosa
ES2713529T3 (es) 2011-06-01 2019-05-22 Prec Biosciences Inc Procedimientos y productos para la producción de líneas celulares de mamífero modificadas con transgenes amplificados
US9758796B2 (en) 2011-06-10 2017-09-12 Basf Plant Science Company Gmbh Nuclease fusion protein and uses thereof
EP2790708B1 (en) 2011-12-16 2024-10-23 Targetgene Biotechnologies Ltd. Compositions and methods for modifying a predetermined target nucleic acid sequence
EP2612918A1 (en) 2012-01-06 2013-07-10 BASF Plant Science Company GmbH In planta recombination
WO2016037164A1 (en) 2014-09-07 2016-03-10 Selecta Biosciences, Inc. Methods and compositions for attenuating gene expression modulating anti-viral transfer vector immune responses
MX2020003838A (es) 2017-10-13 2020-08-06 Selecta Biosciences Inc Metodos y composiciones para atenuar las respuestas de inmunoglobulina m del vector de transferencia antiviral.
KR20200139679A (ko) 2018-02-26 2020-12-14 안톨알엑스, 인크. 면역관용성 리포솜 및 그의 사용 방법
BR112021023594A2 (pt) 2019-05-28 2022-02-08 Selecta Biosciences Inc Métodos e composições para resposta imune de vetor de transferência antiviral atenuada
US20230141563A1 (en) 2021-10-12 2023-05-11 Selecta Biosciences, Inc. Methods and compositions for attenuating anti-viral transfer vector igm responses
US20230357437A1 (en) 2022-03-09 2023-11-09 Selecta Biosciences, Inc. Immunosuppressants in combination with anti-igm agents and related dosing

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993004169A1 (en) * 1991-08-20 1993-03-04 Genpharm International, Inc. Gene targeting in animal cells using isogenic dna constructs
US5792640A (en) * 1992-04-03 1998-08-11 The Johns Hopkins University General method to clone hybrid restriction endonucleases using lig gene
US5436150A (en) * 1992-04-03 1995-07-25 The Johns Hopkins University Functional domains in flavobacterium okeanokoities (foki) restriction endonuclease
US5792632A (en) * 1992-05-05 1998-08-11 Institut Pasteur Nucleotide sequence encoding the enzyme I-SceI and the uses thereof
US5474896A (en) * 1992-05-05 1995-12-12 Institut Pasteur Nucleotide sequence encoding the enzyme I-SceI and the uses thereof
US6395959B1 (en) * 1992-05-05 2002-05-28 Institut Pasteur Nucleotide sequence encoding the enzyme I SceI and the use thereof
US5830729A (en) * 1996-04-18 1998-11-03 Institut Pasteur I Sce I-induced gene replacement and gene conversion in embryonic stem cells
US6265196B1 (en) * 1996-05-07 2001-07-24 Johns Hopkins University Methods for inactivating target DNA and for detecting conformational change in a nucleic acid
JP2002535995A (ja) * 1999-02-03 2002-10-29 ザ チルドレンズ メディカル センター コーポレイション 染色体標的部位での二本鎖dna切断の誘導を含む遺伝子修復
WO2000046385A1 (en) * 1999-02-03 2000-08-10 The Children's Medical Center Corporation Gene repair involving in vivo excision of targeting dna
US6794136B1 (en) * 2000-11-20 2004-09-21 Sangamo Biosciences, Inc. Iterative optimization in the design of binding proteins
DE10131786A1 (de) * 2001-07-04 2003-01-16 Sungene Gmbh & Co Kgaa Rekombinationssysteme und Verfahren zum Entfernen von Nukleinsäuresequenzen aus dem Genom eukaryotischer Organismen
US7314712B2 (en) * 2001-07-27 2008-01-01 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Systems for in vivo site-directed mutagenesis using oligonucleotides
AU2003251286B2 (en) * 2002-01-23 2007-08-16 The University Of Utah Research Foundation Targeted chromosomal mutagenesis using zinc finger nucleases
AU2003215869B2 (en) * 2002-03-15 2008-04-24 Cellectis Hybrid and single chain meganucleases and use thereof
JP2006502748A (ja) * 2002-09-05 2006-01-26 カリフォルニア インスティテュート オブ テクノロジー 遺伝子ターゲッティングを誘発するキメラヌクレアーゼの使用方法
US7285699B2 (en) * 2002-10-07 2007-10-23 Stowers Institute For Medical Research Ends-out gene targeting method
US20030175968A1 (en) * 2002-10-30 2003-09-18 Golic Kent G. Gene targeting method
AU2004208031B2 (en) * 2003-01-28 2009-10-08 Cellectis Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof.
US7888121B2 (en) * 2003-08-08 2011-02-15 Sangamo Biosciences, Inc. Methods and compositions for targeted cleavage and recombination
ATE514782T1 (de) * 2003-11-18 2011-07-15 Bayer Bioscience Nv Verbesserte gezielte dna insertion in pflanzen
WO2006097875A1 (en) * 2005-03-14 2006-09-21 Koninklijke Philips Electronics N.V. Method of producing a component with a surface structure, ceramic component and application of such a method
EP2650366B1 (en) * 2005-10-18 2017-03-22 Precision Biosciences Rationally designed meganucleases with altered sequence specificity and DNA-binding affinity
WO2007060495A1 (en) * 2005-10-25 2007-05-31 Cellectis I-crei homing endonuclease variants having novel cleavage specificity and use thereof

Similar Documents

Publication Publication Date Title
JP2017051190A5 (enExample)
ES2626025T3 (es) Meganucleasas diseñadas racionalmente con especificidad de secuencia y afinidad de unión a ADN alteradas
ES3055163T3 (en) Class ii, type ii crispr systems
Grabher et al. Highly efficient zebrafish transgenesis mediated by the meganuclease I-SceI
JP6948718B2 (ja) ゲノム編集方法
US9840696B2 (en) Nucleic acids encoding SB10 variants
EP3263708B1 (en) Protein with recombinase activity for site-specific dna-recombination
JP2022520428A (ja) Ruvcドメインを有する酵素
KR20200103769A (ko) 연장된 단일 가이드 rna 및 그 용도
US20150128300A1 (en) Methods and compositions for generating conditional knock-out alleles
Xu Microinjection and micromanipulation: a historical perspective
JP2016138104A (ja) ジンクフィンガーヌクレアーゼを使ったrosa遺伝子座のゲノム編集
PE20191203A1 (es) Variantes de alfa-glucosidasa acida y usos de las mismas
RU2009106118A (ru) Способ получения конъюгатов инсулино-подобного фактора роста i и поли(этиленгликоля)
DE602006014107D1 (de) I-crei-meganuklease-varianten mit modifizierter spezifität sowie verfahren zu ihrer herstellung und verwendung
CN103966245B (zh) 利用基因敲入和核移植技术在转基因动物生产重组人丁酰胆碱酯酶的方法
Lee et al. Generation of genetically-engineered animals using engineered endonucleases
WO2011073925A9 (en) C. histolyticum recombinant collagenases and method for the manufacture thereof
Saunders The history of transgenesis
CN105018523A (zh) 一种zb转座子系统及其介导的基因转移方法
Navarro-Serna et al. Effect of aphidicolin, a reversible inhibitor of eukaryotic nuclear DNA replication, on the production of genetically modified porcine embryos by CRISPR/Cas9
Guan et al. Generation of site-specific mutations in the rat genome via CRISPR/Cas9
CN104946621A (zh) 基因敲入组合物及其使用方法和应用
Salamone et al. Transgenesis in farm animals
AU2010340358A1 (en) Recombinant butyrylcholinesterases and truncates thereof